Investment Promotion Scheme (IPS) 2022- for Thrust Sectors: Scheme For Vaccine Manufacturing Units
By Department of Industries, UT Administration of Dadra and Nagar Haveli and Daman and Diu
Check your eligibility
Sign up and we'll tell you whether your startup qualifies for this grant.
Quick Answer
Provides credit-linked interest subsidy up to ₹3 crore and capital investment subsidy up to ₹10 crore for vaccine manufacturing units in Dadra & Nagar Haveli and Daman & Diu.
- Funding amount
- Up to ₹13Cr
- Funding type
- Subsidy
- Application deadline
- Rolling
- Registrations needed
- Udyam registration
About this subsidy
The Investment Promotion Scheme (IPS) 2022, launched on May 7, 2022, is an initiative by the Department of Industries, U.T. Administration of Dadra & Nagar Haveli and Daman & Diu, designed to boost industrial growth and entrepreneurship in identified thrust sectors. This umbrella scheme aims to provide comprehensive incentives and assistance to the MSME sector, fostering a vibrant and successful business environment while protecting enterprises from market fluctuations.
Key objectives of the broader IPS 2022 include doubling the value of exports from processed products, establishing the U.T. as a manufacturing hub for specific products, promoting environmental protection measures, reducing unemployment by incentivizing local labor, maximizing women's participation in business, supporting first-generation entrepreneurs, honing youth entrepreneurship skills, and encouraging innovation through R&D and patenting.
The "Scheme For Vaccine Manufacturing Units" is a dedicated sub-scheme under IPS 2022, specifically targeting the critical health and biotech sector. It is designed to provide significant financial support to entities engaged in vaccine production. Through this sub-scheme, eligible vaccine manufacturing units can access both credit-linked interest subsidies and substantial capital investment subsidies, aiming to make the U.T. a key center for vaccine production and related innovation. The scheme particularly encourages new enterprises and existing ones undertaking expansion or diversification, ensuring robust growth in this vital sector.
Eligibility
See if you're eligible
Full eligibility criteria — entity type, stage, sector, founder profile and registration requirements — plus your fit for this program. Sign up to view.
Subsidy providers
Provider
Department of Industries, UT Administration of Dadra and Nagar Haveli and Daman and DiuDadra and Nagar Haveli and Daman and Diu · India
Benefits & Funding
- Amount
- Up to ₹13Cr
What You Get
The "Scheme For Vaccine Manufacturing Units" offers substantial financial support to eligible enterprises through a combination of subsidies.
- Credit-Linked Interest Subsidy: Enterprises can receive an interest subsidy equivalent to 70% of the interest charged by the bank. This subsidy has an upper ceiling of ₹60 Lakhs per annum and is provided for a period of 5 years or for the entire repayment period of the loan, whichever is earlier. This significant reduction in interest burden aims to make credit more accessible and affordable for vaccine manufacturers. The subsidy will be directly credited to the Bank/Financial Institution.
- Capital Investment Subsidy: A capital investment subsidy of 15% of the investment is provided, up to a maximum of ₹10 crores. This subsidy directly supports enterprises in making gross fixed capital investments in new buildings, plant & machinery, and equipment, thereby encouraging the establishment and expansion of state-of-the-art vaccine manufacturing facilities. This benefit is crucial for scaling up production capabilities and adopting advanced technologies.
- Disbursement
- Reimbursement
- Duration
- 61 months
- Bootstrap friendly
- Yes
Timelines & Process
Applications
Rolling basis
Selection Process
While the specific selection criteria and committee structure are not explicitly detailed, applications for the Investment Promotion Scheme for Vaccine Manufacturing Units will likely undergo a rigorous evaluation. The process typically involves an initial screening to ensure compliance with all eligibility criteria, including enterprise status (new/existing), investment type (GFCI), financial institution loan approval, and adherence to application timelines. Applications meeting these prerequisites would then be reviewed by a committee comprising representatives from the Department of Industries and potentially other relevant U.T. administration bodies. This committee would assess the proposed investment, the enterprise's commitment to production and employment, and its potential contribution to the U.T.'s industrial objectives, particularly in the vaccine manufacturing sector. Approval would be granted to enterprises demonstrating strong adherence to scheme guidelines and significant economic impact.
Application Process
- 1
Register on Portal
Create an account on the Single Window Portal by providing necessary details and verifying email and mobile number.
You - 2
- 3
- 4
- 5
How to apply
Four steps from draft to disbursement — one action each.
- 1
See the questions before you start
Download every question this programme's application form asks, so you can prepare your answers offline before opening the portal.
- 2
Line up your documents
Keep every document from the checklist ready in one folder. Missing docs are the #1 reason applications get bounced.
- 3
Submit on the official portal
Use the official application link and verify all details before final submission.
- 4
Follow up
Reach out 5–7 days after submitting to confirm receipt and ask about the review timeline.
Program templates & documents
Files the program publishes for applicants — download these and apply in the prescribed format.
Frequently Asked Questions
What is the main objective of the Investment Promotion Scheme (IPS) 2022 for Vaccine Manufacturing Units?
The primary objective is to provide credit-linked interest subsidy and capital subsidy to new and existing vaccine manufacturing units, fostering industrial growth, innovation, and job creation in the Union Territory of Dadra & Nagar Haveli and Daman & Diu.
Who is eligible to apply for this scheme?
The scheme is open to new enterprises and existing enterprises that have commenced commercial production during the operative period. It also targets enterprises undertaking significant expansion or diversification with substantial investment in gross fixed capital.
What kind of financial support can an eligible unit expect?
Eligible units can receive a credit-linked interest subsidy up to ₹60 Lakhs per annum for 5 years on bank loans, and a capital investment subsidy of 15% of the investment, capped at ₹10 crores, for new plant, machinery, and building investments.
Is there a deadline to apply for the scheme?
The scheme operates for five years from its launch in May 2022. Enterprises must apply online within one year from the date of the first disbursement of their loan or the date of commencement of commercial production, whichever is later. This provides a flexible application window based on the enterprise's development.
Is it mandatory to secure a bank loan to avail the benefits?
Yes, the interest subsidy is credit-linked, meaning it is tied to a term loan sanctioned by a bank or financial institution as per RBI guidelines. Additionally, enterprises must bear a minimum of 2% of the interest levied on the term loan.
What are the obligations for enterprises receiving the subsidy?
Beneficiary enterprises must submit annual information on production, sales, turnover, and employment. They must also comply with pollution control measures and maintain commercial production for at least five years from its commencement; failure to do so may result in recovery of the capital investment subsidy.
Sources
Data on this page is compiled from official program and provider references.
